PT82150B - Processo de preparacao de composicoes polimericas para administracao parenterica, que se podem dispersar e que sao soluveis na agua, contendo um complexo entre uma proteina e um hidrato de carbono - Google Patents

Processo de preparacao de composicoes polimericas para administracao parenterica, que se podem dispersar e que sao soluveis na agua, contendo um complexo entre uma proteina e um hidrato de carbono

Info

Publication number
PT82150B
PT82150B PT82150A PT8215086A PT82150B PT 82150 B PT82150 B PT 82150B PT 82150 A PT82150 A PT 82150A PT 8215086 A PT8215086 A PT 8215086A PT 82150 B PT82150 B PT 82150B
Authority
PT
Portugal
Prior art keywords
parenteric
soluable
administration
protein
dispersed
Prior art date
Application number
PT82150A
Other languages
English (en)
Other versions
PT82150A (en
Inventor
Susan Mancini Cady
Richard Fishbein
Ulf Schroder
Hakan Eriksson
Brenda Lee Probasco
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE8501094A external-priority patent/SE8501094D0/xx
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of PT82150A publication Critical patent/PT82150A/pt
Publication of PT82150B publication Critical patent/PT82150B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pens And Brushes (AREA)
  • Organic Insulating Materials (AREA)
PT82150A 1985-03-06 1986-03-06 Processo de preparacao de composicoes polimericas para administracao parenterica, que se podem dispersar e que sao soluveis na agua, contendo um complexo entre uma proteina e um hidrato de carbono PT82150B (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE8501094A SE8501094D0 (sv) 1985-03-06 1985-03-06 Biologiskt aktiv komposition och forfarande for framstellning derav
US71741785A 1985-03-29 1985-03-29
US83015886A 1986-02-20 1986-02-20

Publications (2)

Publication Number Publication Date
PT82150A PT82150A (en) 1986-04-01
PT82150B true PT82150B (pt) 1988-02-17

Family

ID=27355321

Family Applications (1)

Application Number Title Priority Date Filing Date
PT82150A PT82150B (pt) 1985-03-06 1986-03-06 Processo de preparacao de composicoes polimericas para administracao parenterica, que se podem dispersar e que sao soluveis na agua, contendo um complexo entre uma proteina e um hidrato de carbono

Country Status (11)

Country Link
EP (1) EP0193917A3 (pt)
KR (1) KR890004687B1 (pt)
AU (1) AU591478B2 (pt)
DK (1) DK100686A (pt)
ES (1) ES8704347A1 (pt)
FI (1) FI860923L (pt)
GR (1) GR860610B (pt)
IL (1) IL78031A0 (pt)
NO (1) NO860832L (pt)
NZ (1) NZ215366A (pt)
PT (1) PT82150B (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4786501A (en) * 1985-07-15 1988-11-22 International Minerals & Chemical Corp. Cylindrical implants for the controlled release of growth hormones
CA1296253C (en) * 1986-10-20 1992-02-25 Praveen Tyle Stabilized growth hormone compositions
NZ235556A (en) * 1986-11-05 1991-06-25 Ethicon Inc Breast milk substitute containing recombinant human egf
US4857506A (en) * 1987-01-12 1989-08-15 American Cyanamid Company Sustained release growth hormone compositions for parenteral administration and their use
US4857505A (en) * 1987-03-09 1989-08-15 American Cyanamid Company Sustained release compositions for parenteral administration and their use
US4863736A (en) 1987-03-16 1989-09-05 Monsanto Company Somatotropin prolonged release
EP0303746B2 (en) * 1987-08-21 1998-12-02 Mallinckrodt Group Inc. Stabilization of growth promoting hormones
NZ226170A (en) * 1987-09-18 1990-07-26 Ethicon Inc Stable freeze-dried pharmaceutical composition containing epidermal growth factor
GB8725427D0 (en) * 1987-10-30 1987-12-02 Lilly Industries Ltd Somatotropin formulations
US5096885A (en) * 1988-04-15 1992-03-17 Genentech, Inc. Human growth hormone formulation
US5981485A (en) 1997-07-14 1999-11-09 Genentech, Inc. Human growth hormone aqueous formulation
US5763394A (en) * 1988-04-15 1998-06-09 Genentech, Inc. Human growth hormone aqueous formulation
FR2637501A1 (fr) * 1988-10-07 1990-04-13 Inst Develop Valorisa Biotec Composition stabilisee a base de facteurs de croissance de la famille fgf et de dextrane sulfate, et ses applications
JPH04502768A (ja) * 1989-01-26 1992-05-21 アボット　バイオテク，インコーポレイテッド 疎水性蛋白質水溶液の安定化及び持続的放出ビヒクル
US5422340A (en) * 1989-09-01 1995-06-06 Ammann; Arthur J. TGF-βformulation for inducing bone growth
AU653325B2 (en) * 1990-02-12 1994-09-29 Lucky Limited A composition durably releasing bioactive polypeptides
US5681814A (en) * 1990-06-07 1997-10-28 Genentech, Inc. Formulated IGF-I Composition
NZ234439A (en) * 1990-07-10 1997-08-22 Pharmacia & Upjohn Ab Use of igf-1 to reduce fetal growth retardation in non human mammals
US5714458A (en) * 1990-07-18 1998-02-03 Farmitalia Carlo Erba S.R.L. Stable pharmaceutical compositions containing a fibroblast growth factor
IE912345A1 (en) * 1990-08-03 1992-02-12 Pharmacia Ab Treatment of human lactation failure
GB9102107D0 (en) * 1991-01-31 1991-03-13 Erba Carlo Spa Stabilisation of fibroblast growth factor using a polysaccharide
US5192743A (en) * 1992-01-16 1993-03-09 Genentech, Inc. Reconstitutable lyophilized protein formulation
AU685784B2 (en) * 1993-02-23 1998-01-29 Genentech Inc. Excipient stabilization of polypeptides treated with organic solvents
US6277828B1 (en) * 1993-08-20 2001-08-21 Syntex (U.S.A.) Inc. Pharmaceutical formulations of nerve growth factor
ZA949350B (en) 1994-01-25 1996-05-24 Upjohn Co Aqueous prolonged release formulation
KR19990071255A (ko) 1998-02-28 1999-09-15 성재갑 소마토트로핀과 비타민의 합제 조성물
DE19907257A1 (de) * 1999-02-21 2000-09-14 Bernd Horst Meier Mittel zur Steuerung der Diffusion von Injektionslösungen
US7052721B2 (en) 2000-04-05 2006-05-30 Hafsteinn Helgason Recovery of compounds using a natural adsorbent
EP2700431A1 (en) 2012-08-24 2014-02-26 AnalytiCon Discovery GmbH Plant extracts for modulating TRPV1 function

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE396693B (sv) * 1970-02-16 1977-10-03 Paulsen Fredrik Sett att framstella komplex av syntetiskt kortikotropin med forsterkt och forlengd verkan
GB1345513A (en) * 1973-01-12 1974-01-30 Vosper Thornycroft Ltd Gas cushion vehicle
FR2265043A1 (en) * 1974-03-18 1975-10-17 Dietrich & Cie De Roasting oven with several spits - has single motor turning all spits together through common crank plate
DE2512943A1 (de) * 1974-04-02 1975-10-16 Sandoz Ag Verfahren zur herstellung protrahiert wirksamer injektionspraeparate
EP0085036A1 (en) * 1982-01-18 1983-08-03 Monsanto Company Method for improved bovine milk production
US4457916A (en) * 1982-08-31 1984-07-03 Asahi Kasei Kogyo Kabushiki Kaisha Method for stabilizing Tumor Necrosis Factor and a stable aqueous solution or powder containing the same
EP0123291A2 (en) * 1983-04-20 1984-10-31 Kyowa Hakko Kogyo Co., Ltd. Method for stabilizing interferon
JPS60258125A (ja) * 1984-06-06 1985-12-20 Hayashibara Biochem Lab Inc 蛋白性生理活性物質を含有する水溶性乾燥物
DE3500268A1 (de) * 1985-01-05 1986-07-10 Hoechst Ag, 6230 Frankfurt Praeparate mit verzoegerter wirkung, verfahren zu deren herstellung sowie entsprechende mittel zur human- bzw. veterinaermedizinischen anwendung

Also Published As

Publication number Publication date
AU591478B2 (en) 1989-12-07
NO860832L (no) 1986-09-08
EP0193917A2 (en) 1986-09-10
PT82150A (en) 1986-04-01
NZ215366A (en) 1988-07-28
AU5430686A (en) 1986-10-16
EP0193917A3 (en) 1987-09-23
KR860006985A (ko) 1986-10-06
FI860923A7 (fi) 1986-09-07
FI860923A0 (fi) 1986-03-05
ES552690A0 (es) 1987-04-01
IL78031A0 (en) 1986-07-31
DK100686D0 (da) 1986-03-05
ES8704347A1 (es) 1987-04-01
GR860610B (en) 1986-06-30
DK100686A (da) 1986-09-07
FI860923L (fi) 1986-09-07
KR890004687B1 (ko) 1989-11-25

Similar Documents

Publication Publication Date Title
PT82150B (pt) Processo de preparacao de composicoes polimericas para administracao parenterica, que se podem dispersar e que sao soluveis na agua, contendo um complexo entre uma proteina e um hidrato de carbono
BR8506169A (pt) Alvejantes contendo halogenio encapsulado e processo para sua preparacao e utilizacao
BR8502688A (pt) Granulo contendo substancia fisiologicamente ativa,processo para preparar o mesmo e processo para criar ruminantes
ES2015044B3 (es) Proceso para la preparacion de aglomerados que contienen acido diperoxido-decanodioico y su uso en composiciones de blanqueo.
FI863996A7 (fi) Kationista bentsidiinin merikinonia sisältäviä ionisia yhdisteitä ja niiden käyttö biologisten aineiden visualisoinnissa.
AU5414986A (en) Oil in water emulsion sunscreen composition
PT82030B (pt) Processo para a preparacao de derivados de androstenodiona substituidos na posicao 4 e de composicoes farmaceuticas que os contem
DK159848C (da) 7-hydroxy-1,2,3,4,4a,5,6,10b-oktahydrobenzo(f)-quinoliner eller farmaceutisk acceptable syreadditionssalte deraf samt farmaceutiske praeparater indeholdende saadanne forbindelser
PT82985B (pt) Processo para a preparacao de derivados de distamicina e de composicoes farmaceuticas que os contem
IT8548836A0 (it) Perfezionamento nei dentifrici in gel e procedimento di preparazione
IL78843A (en) Salts of n-acyl-thiazolidine-4-carboxylic acid with 6-piperidino-2-4-diaminopyrimidine-3-oxide and pharmaceutical and cosmetic compositions containing them
EP0227980A3 (en) Fluorescent aroxysubstituted 3,4,9,10-perylenetetracarboxylic acid-diimides and their use for the concentration of lights in small areas
FI903233A7 (fi) Orgaanisia sulfoneja ja sulfoksideja sisältävät nestekoostumukset
IT1177580B (it) Composizione farmaceutica contenente rifampicina e procedimento per prepararla
AR229552A1 (es) Composicion en barra de gel cosmetico y procedimiento para prepararla
MX163957B (es) Procedimiento para la preparacion de soluciones de jabon de metal mixtas que contienen vanadio
GB2126089B (en) Composition of matter containing imidazolidinyl urea and parabens
PT83419B (pt) Processo para a preparacao de 2-aminopurinas substituidas nas posicoes 6 e 9 e de composicoes farmaceuticas que contem estas purinas
IT8567849A0 (it) Procedimento per la preparazione dil carnitina e suoi sali
IT1191639B (it) Composizione farmaceutica contenente fosfocreatina e metodo per preparla
DK160873C (da) Benzoquinolizinderivater samt farmaceutisk acceptable syreadditionssalte deraf og farmaceutisk middel indeholdende saadanne forbindelser og dettes fremstilling
PT83305B (pt) Processo para a preparacao de derivados de xantina e de composicoes farmaceuticas que os contem
BR8305498A (pt) Aperfeicoamentos introduzidos nos meios e no processo de elaboracao,para queima,de emulsao contendo agua e oleo combustivel
TR23367A (tr) Diflorohalometoksifenil tuerevi ve adi gecen tuerevi etkili terkip maddesi olarak iceren mitisid
DE3664906D1 (en) Liquid cristalline compositions containing cyclohexylcyclohexene derivatives, and their use

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19910206